Ida Vind

Ida Vind

Clinical Associate Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


Publication year:
All
1 - 10 out of 49Page size: 10
  1. 2024
  2. E-pub ahead of print

    Specific Antibiotics Increase the Risk of Flare-Ups in Patients with Inflammatory Bowel Disease: Results from a Danish Nationwide Population-Based Nested Case-Control Study

    Lo, B., Biederman, L., Rogler, G., Dora, B., Kreienbühl, A., Vind, Ida, Bendtsen, Flemming & Burisch, J., 17 Feb 2024, (E-pub ahead of print) In: Journal of Crohn's & colitis. 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. E-pub ahead of print

    Building an AI Support Tool for Real-Time Ulcerative Colitis Diagnosis

    Møller, Bjørn Leth, Lo, B. Z. S., Burisch, J., Bendtsen, Flemming, Vind, Ida, Ibragimov, Bulat & Igel, Christian, 2024, (E-pub ahead of print) In: KI - Künstliche Intelligenz. 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2023
  5. Published

    I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    I-CARE Collaborator Group, I. C. G., 2023, In: Clinical Gastroenterology and Hepatology. 21, 3, p. 771-788.e10 28 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2022
  7. Published

    Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease

    Buhl, S., Steenholdt, C., Brynskov, J., Christensen, K. R., Dorn-rasmussen, M., Thomsen, O. Ø., Bendtzen, K., Klausen, T. W., Dahlerup, J. F., Thorsgaard, N., Jahnsen, J., Molazahi, A., Pedersen, N., Kjeldsen, J., Almer, S., Dahl, E. E., Vind, I., Cannon, A. G., Marsal, J., Sipponen, T. & 7 others, Agnholt, J. S., Kievit, H. A. L., Aure, S. L., Martinsen, L., Meisner, S., Hansen, J. M. & Ainsworth, M. A., 2022, In: NEJM Evidence. 1, 8, 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    High accuracy in classifying endoscopic severity in ulcerative colitis using convolutional neural network

    Lo, B., Liu, Z., Bendtsen, Flemming, Igel, Christian, Vind, Ida & Burisch, J., 2022, In: The American Journal of Gastroenterology. 117, 10, p. 1648-1654

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020

    Wewer, M. D., Arp, L., Sarikaya, M., Felding, O. K., Vind, Ida, Pedersen, G., Mertz-Nielsen, A., Kiszka-Kanowitz, M., Boysen, T., Theede, K., Petersen, Andreas Munk, Nordgaard-Lassen, I., Bendtsen, Flemming & Burisch, J., 2022, In: Crohn's and Colitis 360. 4, 4, otac041.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2021
  11. Published

    Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study

    Attauabi, M., Vind, Ida, Pedersen, G., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2021, In: European journal of gastroenterology & hepatology. 33, 15, p. 709-718

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study

    for the NOVA Study Group, F. T. N. S. G., 2021, In: Alimentary Pharmacology and Therapeutics. 54, 10, p. 1320-1329 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies

    Lo, B., Zhao, M., Vind, Ida & Burisch, J., 2021, In: Clinical Gastroenterology and Hepatology. 19, 6, p. 1117-1138.e19 41 p.

    Research output: Contribution to journal › Review › Research › peer-review

  14. 2020
  15. Published

    Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study

    Burisch, J., Vardi, H., Schwartz, D., Friger, M., Kiudelis, G., Kupčinskas, J., Fumery, M., Gower-rousseau, C., Lakatos, L., Lakatos, P. L., D'incà, R., Sartini, A., Valpiani, D., Giannotta, M., Arebi, N., Duricova, D., Bortlik, M., Chetcuti Zammit, S., Ellul, P., Pedersen, N. & 31 others, Kjeldsen, J., Midjord, J. M. M., Nielsen, K. R., Winther Andersen, K., Andersen, V., Katsanos, K. H., Christodoulou, D. K., Domislovic, V., Krznaric, Z., Sebastian, S., Oksanen, P., Collin, P., Barros, L., Magro, F., Salupere, R., Kievit, H. A. L., Goldis, A., Kaimakliotis, I. P., Dahlerup, J. F., Eriksson, C., Halfvarson, J., Fernandez, A., Hernandez, V., Turcan, S., Belousova, E., Langholz, Ebbe, Munkholm, Pia, Odes, S., Turk, N., Vind, Ida & Epi-IBD group, E. G., 1 May 2020, In: The Lancet Gastroenterology and Hepatology. 5, 5, p. 454-464 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 Next

ID: 21472222